Startup Bionamic has raised € 350 000 (SEK 4 million), VC firm I Love Lund announced. The startup, founded in 2019, is preparing for a significant expansion phase in Europe in the next years with its AI and data-driven platform for biopharma teams.
This platform aims to simplify data management in R&D for biological drugs, enhancing research efficiency through AI. With the investment, Bionamic, which has recently acquired major clients in Switzerland and Canada, plans to reach break-even by 2025.
“In Bionamic, there is the competence and potential whose innovative power can be combined with sales-focused strength. This will be able to deliver both good value development and benefit for Lund. Our contribution of capital and network competencies should make a difference in Bionamic,”
says I Love Lund’s CEO Björn Englund.
In addition to I Love Lund, existing owners such as LU Holding (Lund University’s investment company), and Fårö Capital have invested.
The startup released a pilot in 2020 and today the product is used by five customers, and another four customers are in the test phase. In 2023, the company had a turnover of around SEK 1.5 million.
“Bionamic benefits greatly from the university and the local biotech scene. Having I Love Lund on the list of owners further strengthens our ties to the local ecosystem and we look forward to being able to reach out with our concept to even more interested parties,”
says Dr. Anders Carlsson, Bionamic’s CEO and founder.
